Literature DB >> 7609032

Analysis of the cleavage site of the human immunodeficiency virus type 1 glycoprotein: requirement of precursor cleavage for glycoprotein incorporation.

J W Dubay1, S R Dubay, H J Shin, E Hunter.   

Abstract

Endoproteolytic cleavage of the glycoprotein precursor to the mature SU and TM proteins is an essential step in the maturation of retroviral glycoproteins. Cleavage of the precursor polyprotein occurs at a conserved, basic tetrapeptide sequence and is carried out by a cellular protease. The glycoprotein of the human immunodeficiency virus type 1 contains two potential cleavage sequences immediately preceding the N terminus of the TM protein. To determine the functional significance of these two potential cleavage sites, a series of mutations has been constructed in each site individually, as well as in combinations that altered both sites simultaneously. A majority of the mutations in either potential cleavage site continued to allow efficient cleavage when present alone but abrogated cleavage of the precursor when combined. Despite being transported efficiently to the cell surface, these cleavage-defective glycoproteins were unable to initiate cell-cell fusion and viruses containing them were not infectious. Viruses that contained glycoproteins with a single mutation, and that retained the ability to be processed, were capable of mediating a productive infection, although infectivity was impaired in several of these mutants. Protein analyses indicated that uncleaved glycoprotein precursors were inefficiently incorporated into virions, suggesting that cleavage of the glycoprotein may be a prerequisite to incorporation into virions. The substitution of a glutamic acid residue for a highly conserved lysine residue in the primary cleavage site (residue 510) had no effect on glycoprotein cleavage or function, even though it removed the only dibasic amino acid pair in this site. Peptide sequencing of the N terminus of gp41 produced from this mutant glycoprotein demonstrated that cleavage continued to take place at this site. These results, demonstrating that normal cleavage of the human immunodeficiency virus type 1 glycoprotein can occur when no dibasic sequence is present at the cleavage site, raise questions about the specificity of the cellular protease that mediates this cleavage and suggest that cleavage of the glycoprotein is required for efficient incorporation of the glycoprotein into virions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7609032      PMCID: PMC189271          DOI: 10.1128/JVI.69.8.4675-4682.1995

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  Effects of amino acid replacements within the tetrabasic cleavage site on the processing of the human insulin receptor precursor expressed in Chinese hamster ovary cells.

Authors:  Y Yoshimasa; J I Paul; J Whittaker; D F Steiner
Journal:  J Biol Chem       Date:  1990-10-05       Impact factor: 5.157

2.  Changes in the transmembrane region of the human immunodeficiency virus type 1 gp41 envelope glycoprotein affect membrane fusion.

Authors:  E Helseth; U Olshevsky; D Gabuzda; B Ardman; W Haseltine; J Sodroski
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

3.  Intracellular processing of the gp160 HIV-1 envelope precursor. Endoproteolytic cleavage occurs in a cis or medial compartment of the Golgi complex.

Authors:  B S Stein; E G Engleman
Journal:  J Biol Chem       Date:  1990-02-15       Impact factor: 5.157

4.  Identification of a cDNA encoding a second putative prohormone convertase related to PC2 in AtT20 cells and islets of Langerhans.

Authors:  S P Smeekens; A S Avruch; J LaMendola; S J Chan; D F Steiner
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-15       Impact factor: 11.205

Review 5.  Viral and cellular membrane fusion proteins.

Authors:  J M White
Journal:  Annu Rev Physiol       Date:  1990       Impact factor: 19.318

6.  Mutational analysis of the cleavage sequence of the human immunodeficiency virus type 1 envelope glycoprotein precursor gp160.

Authors:  E O Freed; D J Myers; R Risser
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

7.  Expression of a human proprotein processing enzyme: correct cleavage of the von Willebrand factor precursor at a paired basic amino acid site.

Authors:  R J Wise; P J Barr; P A Wong; M C Kiefer; A J Brake; R J Kaufman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

8.  Identification of a human insulinoma cDNA encoding a novel mammalian protein structurally related to the yeast dibasic processing protease Kex2.

Authors:  S P Smeekens; D F Steiner
Journal:  J Biol Chem       Date:  1990-02-25       Impact factor: 5.157

9.  Mutational analysis of the human immunodeficiency virus type 1 env gene product proteolytic cleavage site.

Authors:  V Bosch; M Pawlita
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

10.  Virion incorporation of envelope glycoproteins with long but not short cytoplasmic tails is blocked by specific, single amino acid substitutions in the human immunodeficiency virus type 1 matrix.

Authors:  E O Freed; M A Martin
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

View more
  46 in total

1.  Variable-loop-deleted variants of the human immunodeficiency virus type 1 envelope glycoprotein can be stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits.

Authors:  R W Sanders; L Schiffner; A Master; F Kajumo; Y Guo; T Dragic; J P Moore; J M Binley
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

2.  The entire SU subunit is required for the incorporation of the HIV-1 envelope glycoprotein complex into virions.

Authors:  Y Y Li; L G Perez
Journal:  Virus Genes       Date:  1997       Impact factor: 2.332

3.  An evolutionarily conserved positively charged amino acid in the putative membrane-spanning domain of the foamy virus envelope protein controls fusion activity.

Authors:  T Pietschmann; H Zentgraf; A Rethwilm; D Lindemann
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

4.  Characterization of the R572T point mutant of a putative cleavage site in human foamy virus Env.

Authors:  A Bansal; K L Shaw; B H Edwards; P A Goepfert; M J Mulligan
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

5.  Heterogeneity of envelope molecules expressed on primary human immunodeficiency virus type 1 particles as probed by the binding of neutralizing and nonneutralizing antibodies.

Authors:  Pascal Poignard; Maxime Moulard; Edwin Golez; Veronique Vivona; Michael Franti; Sara Venturini; Meng Wang; Paul W H I Parren; Dennis R Burton
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

6.  Evaluating the immunogenicity of a disulfide-stabilized, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1.

Authors:  Simon Beddows; Norbert Schülke; Marc Kirschner; Kelly Barnes; Michael Franti; Elizabeth Michael; Thomas Ketas; Rogier W Sanders; Paul J Maddon; William C Olson; John P Moore
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

7.  A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure.

Authors:  J M Binley; R W Sanders; B Clas; N Schuelke; A Master; Y Guo; F Kajumo; D J Anselma; P J Maddon; W C Olson; J P Moore
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

8.  Specific in vitro cleavage of a Leishmania virus capsid-RNA-dependent RNA polymerase polyprotein by a host cysteine-like protease.

Authors:  Y T Ro; S M Scheffter; J L Patterson
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

9.  In-solution virus capture assay helps deconstruct heterogeneous antibody recognition of human immunodeficiency virus type 1.

Authors:  Daniel P Leaman; Heather Kinkead; Michael B Zwick
Journal:  J Virol       Date:  2010-01-20       Impact factor: 5.103

10.  Assembly of arenavirus envelope glycoprotein GPC in detergent-soluble membrane microdomains.

Authors:  Sudhakar S Agnihothram; Brooke Dancho; Kenneth W Grant; Mark L Grimes; Douglas S Lyles; Jack H Nunberg
Journal:  J Virol       Date:  2009-07-22       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.